Humana reported stronger-than-expected Q3 2026 financial results, with revenue exceeding consensus estimates and a smaller adjusted loss per share than anticipated. The company also raised its full-year 2026 adjusted earnings guidance, signaling improved profitability outlook.
Humana Inc. announced its Q3 2026 financial results, reporting revenue of $41.16 billion, which surpassed the FactSet consensus of $40.87 billion. Crucially, the company also raised its full-year 2026 adjusted earnings guidance to at least $9.50 per share, up from $9.00, and reported a smaller adjusted loss of $0.70 per share compared to the estimated $1.00 loss. This positive earnings surprise and upward revision in guidance are significant for investors, indicating stronger operational performance and a more optimistic outlook for the company's profitability. This news is a direct positive catalyst for Humana, potentially leading to an upward revision in analyst price targets and increased investor confidence in the short term. For traders, this presents an opportunity for long positions in HUM, as the improved financial health and future projections suggest continued growth.